content

Humanetics receives US DoD funding for Covid-19 drug development

Humanetics has received funding from the US Department of Defense (DoD) to carry out a series of studies with its novel drug candidate, BIO...

Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab with VIR-7831

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients...

Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to...

BC Platforms, RIKEN and the Finnish Institute for Health and Welfare collaborate on AI approach to identify people most at risk of from COVID-19

BC Platforms, a global leader in clinical and genomic data management, analytics and access, announces that it has joined forces with Japanโ€™s RIKEN research...

Dr Reddys Labs, GRA terminate Avigan study for Covid-19 treatment in Kuwait

Dr Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) announced the termination of Avigan trial conducted in Kuwait focused on moderate to severe...

CEVA Logistics signs a MOU with the Hope Consortium to provide logistics support for COVID-19 vaccine distribution worldwide

CEVA Logistics has signed a Memorandum of Understanding with Abu Dhabi Ports to work with the Hope Consortium. The Consortium is the umbrella organization...

Covaxin effectively neutralises UK variants: Bharat Biotech

Vaccine maker Bharat Biotech said that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read